“IP strategy is about picking your battles”
Stuart Boyer brings a practical approach to IP strategy. The important thing, he says, is seeing the part of the puzzle that will matter most in the future.
Although he works on a broad range of patents, Stuart specialises in all aspects of patenting in the fields of biotechnology and molecular biology, working with some of the largest biotechnology and pharmaceutical companies in Europe, the United States and Japan in the successful prosecution of their Australian patent applications and disputes.
The biotech sector, like many other sectors, remains poorly supported by Federal and State governments. Thus the challenge for many Biotech companies remains funding. In a challenging landscape it is important that IP rich businesses have an IP strategy that matches their commercial goals. In other words, it’s not simply about capturing and prosecuting patent applications, it’s about a holistic approach that supports the desired outcome for the client - whether that’s trade sale, IPO or business growth. “It is important to have an IP position in place, it gives the client options for carving out a piece of the commercial landscape further down the track. I see patents as one of the strategic weapons against competitors."
- Doctor of Philosophy (Molecular Biology / Immunology) – University of Western Australia
- Bachelor of Science (Microbiology and Biochemistry) (Honours) – Murdoch University
Registered patent attorney (Australia and New Zealand)
- Graduate of the Australian Institute of Company Directors